Home / Industry / Pharmaceuticals & Biotechnology / Oncology Drugs Market

Oncology Drugs Market

Global Oncology Drugs Industry Analysis, Size, Share, Growth, Trends, and Forecast 2025-2032 - (By Drug Class, By Indication, By Route of Administration, By Distribution Channel, By Geographic Coverage and By Company)

Published Date: Jan 2025 | Format: | No. of Pages: 187

Industry: Pharmaceuticals & Biotechnology | Author Name: Sayali

Request Sample / Information

  
$4,995.00
Buy now
Report Description Research Methodology

FAQ : Oncology Drugs Market

The industry is estimated to be valued at US$ 27.9 Bn in 2025.

The oncology drugs industry is estimated to rise at a CAGR of 6.6% from 2025 to 2032.

Keytruda is projected to be the largest-selling oncology drug in the world, which is gaining impetus among key companies.

The oncology drugs industry is estimated to be valued at US$ 43.8 Bn in 2032.

GlaxoSmithKline, AstraZeneca plc, and AbbVie are the key industry players.
Fairfield Quality assured
Fairfield Confidentiality assured
Fairfield Custom research services